S Mpofu Selected Research

Disease Progression

2/2003

Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Mpofu Research Topics

Disease

3	Rheumatoid Arthritis 10/2011 - 04/2003
1	Abscess 05/2004
1	Renal Insufficiency (Renal Failure) 12/2003
1	Systemic Scleroderma (Systemic Sclerosis) 12/2003
1	Acute Kidney Injury (Acute Renal Failure) 12/2003
1	Relapsing Polychondritis 09/2003
1	Multiple Sclerosis 04/2003
1	Amyloid Plaque 02/2003
1	Amyloidosis 02/2003
1	Necrosis 02/2003
1	Nephrotic Syndrome (Syndrome, Nephrotic) 02/2003
1	Proteinuria 02/2003
1	Rheumatic Diseases (Rheumatism) 02/2003
1	Disease Progression 02/2003
1	Spondylarthropathies 02/2003

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 10/2011
1	SteroidsIBA 05/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2003
1	OxalatesIBA 12/2003
1	Infliximab (Remicade)FDA Link 09/2003
1	Anticardiolipin AntibodiesIBA 04/2003
1	Amyloid (Amyloid Fibrils)IBA 02/2003
1	Serum Amyloid P-ComponentIBA 02/2003
1	Chlorambucil (Leukeran)FDA Link 02/2003
1	Cytostatic AgentsIBA 02/2003
1	AA amyloidosisIBA 02/2003

Therapy/Procedure

2	Therapeutics 12/2003 - 02/2003